For recent MS patients, first-line Kesimpta treatment was tied to a lower risk of disability progression compared with using ...

An earlier start to Ocrevus was linked to slower disability progression over a 10-year period among relapsing and progressive ...

After a year, patients given CNM-Au8 had improvements in vision and data suggested the therapy improved the health of brain ...

Ocrevus was chosen because it works by depleting B-cells, which may play a greater disease-driving role among Black and ...

Undergoing fertility treatment with assistive reproductive technologies does not increase relapse risk for women with MS, an ...

The risk of stroke, a blockage in blood flow to the brain that leads to tissue damage, is about 2.5 times higher in people ...

The National Multiple Sclerosis Society granted $722,602 to Kessler Foundation scientists to study brain networks linked to ...

The use of obesity medications - approved drugs for diabetes and to promote weight loss - is tied to a reduced likelihood of ...

Scientists created an assay that can measure immune cells' response to EBV, which could inform research and clinical trials ...

SpineX completed enrollment in a trial testing its Scone neuromodulation device for people with overactive bladder due to MS, ...

Three distinct immune signatures in the blood could be linked to the course MS takes in patients, and how well they respond ...

Erectile dysfunction occurred more often in men with MS than those without in a study, but the difference wasn't ...